Efficacy of low-dose subcutaneous IL-2 to treat advanced human immunodeficency virus type 1 in persons with \leq250/\mul CD4 T cells and undetectable plasma virus load

A Arnó, L Ruiz, M Juan, A Jou, M Balagué, MK Zayat, S Márfil, J Martínez-Picado, MA Martínez, J Romeu, R Pujol-Borrell, C Lane, B Clotet

Research output: Contribution to journalArticleResearch

108 Citations (Scopus)
Original languageEnglish
Pages (from-to)56-60
JournalJ. infect. dis.
Volume180
Publication statusPublished - 1 Jan 1999

Cite this